Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Forbes Recognizes Beacon College on Accessibility 100 List
-
Statkraft strengthens core activities and competitiveness following strategic review
-
Moleculin Participates in Virtual Investor “What This Means” Segment
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PRIMARY HEALTH PROPERTIES - Ordinary Shares
-
XRP News: Martini Market, The First Decentralized Prediction Markets On XRP Announces Its MRT Token Presale
-
Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia
-
Ekso Bionics’ Acceptance into NVIDIA Connect Program Bears Early Fruit
-
Palvella Therapeutics Granted Sixth U.S. Patent Covering 0.1–20% Anhydrous Compositions of Rapamycin and Other mTOR Inhibitors
-
Statement from Bart Demosky, Executive Vice President and CFO, Bombardier, on S&P’s Global Ratings Upgrade to BB- from B+
-
Bowman Leads $24 Million Water System Upgrades in Del Norte, CO
-
Zefiro Subsidiary Awarded USD $19.6 Million Plugging & Abandonment Management Contract from the Ohio Department of Natural Resources
-
IT Teams are Losing Visibility as Tech Cost Pressures Mount, According to Flexera 2025 State of ITAM Report
-
Novacium Launches Industrial Production of High-Performance Batteries Incorporating Its Silicon-Based Anode Material
-
Purpose Investments Launches Purpose XRP ETF, Adding to Its Diverse and Growing Suite of Digital Asset ETFs
-
Valour Launches Four New ETPs on Spotlight Stock Market: Mantra (OM), Tron (TRX), Stellar (XLM), and Tether Gold (XAUT)
-
Near Surface Infill-Drilling to Assess Open Pit Production Intersects 45.38 g/t Au over 3.13 m core length, including 141.00 g/t Au over 0.88 m
-
Statement from Bart Demosky, Executive Vice President and CFO, Bombardier, on S&P’s Global Ratings Upgrade to BB- from B+
-
Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML
-
Zefiro Subsidiary Awarded USD $19.6 Million Plugging & Abandonment Management Contract from the Ohio Department of Natural Resources
-
Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X
-
XOMA Royalty Declares Quarterly Preferred Stock Dividends
-
Dynacor Group Announces Election of Directors
-
F2G Announces Publication in The Lancet Infectious Diseases of Phase 2b Data Demonstrating Positive Therapeutic Responses in Patients with Serious Invasive Fungal Diseases Treated with Oral Olorofim
-
Gradient Denervation Technologies Announces Acceptance into FDA’s Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System
-
Form 8.3 - [Alpha Group International PLC]
-
Grant of warrants
-
SalMar - Minutes from annual general meeting
-
Microchip Enhances Digital Signal Controller Lineup with Industry-Leading PWM Resolution and ADC Speed
-
SunRocket Capital Provides Financing for Golden Gate Capital's C&I Rooftop Solar Installation in New Jersey
-
SunRocket Capital Provides Financing for Golden Gate Capital's C&I Rooftop Solar Installation in New Jersey
-
Net Asset Value(s)
-
NexGold VP Sustainability Receives Prestigious Mining Society of Nova Scotia Medal
-
Troilus Agrees to Commercial Offtake Terms with Aurubis for Its Copper-Gold Concentrate
-
Eccogene Announces First Patient Dosed in Phase 1b Trial of AZD5004/ECC5004, a Novel Oral GLP-1 Receptor Agonist, in China
-
Central Ossington Opens July 3 – Toronto’s Newest Spot for Food, Cocktails, and Culture
-
A.I.S. Resources Closes Shares for Debt Transaction
-
I-Mab to Host Webinar to Recap New Givastomig Data, in Combination with Immunochemotherapy, Expected at ESMO GI 2025
-
Simply Good Foods to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, July 10, 2025
-
Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) Investor Webinar with Presentation and Audience Q&A
-
3D Systems Announces Issuance of $92 Million of Convertible Senior Secured Notes due 2030 and Retirement of $180 Million of Existing Convertible Senior Notes due 2026
-
Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates
-
BPGbio Announces Presentation of Preliminary Clinical Data of Investigational BPM31510 for Primary CoQ10 Deficiency
-
Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility Upgrades
-
Axsome Therapeutics to Present Data Spanning the SYMBRAVO® (meloxicam and rizatriptan) Clinical Program at the 67th Annual Scientific Meeting of the American Headache Society (AHS)
-
Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer
-
Extensive Greenland Lithium Exploration Campaign Launched by Brunswick Exploration
-
Gogo successfully completes first 5G end-to-end call.
-
Fractyl Health Reinforces Intellectual Property Leadership in Metabolic Disease with Two New U.S. Patents Directed to Duodenal Resurfacing
-
HydroGraph Announces Kjirstin Breure as Board Chair
-
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Wee
